Secondly, a study of the GALNT12 gene demonstrated truncating somatic and germline mutations in CRC patients but none in controls and genetic defects in the O-glycosylation pathway in part underlie aberrant glycosylation, and thereby contribute to the development in a subset of CRC [38]. Here, GALNT12 is linked to colorectal carcinoma.